Showing results (51-60 of 689) with videos related to
Sort By:
Pageof 69
European Journal of Endocrinology|March 7, 2008
Exploiting the antidiabetic properties of incretins to treat type 2 diabetes mellitus: glucagon-like peptide 1 receptor agonists or insulin for patients with inadequate glycemic control?Luc F Van Gaal, Stephen W Gutkin, Michael A NauckDiabetes, Obesity & Metabolism|January 26, 2023
Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin: An update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide/GLP-1 receptor co-agonist tirzepatideMichael A Nauck, Abd El Aziz Mirna, Daniel R QuastDiabetes, Obesity & Metabolism|April 11, 2025
Comparative efficacy and tolerability of currently approved incretin mimetics: A systematic analysis of placebo-controlled clinical trialsYu Mi Kang, Viktoria Punov, Soo Lim, et al.Cardiovascular Diabetology|June 28, 2023
Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis studyMinji Sohn, Johannes W Dietrich, Michael A Nauck, et al.British Journal of Neurosurgery|December 2, 2016
Persistent hemifacial spasm after microvascular decompression: a risk assessment modelAalap Shah, Michael HorowitzDiabetes|October 4, 2013
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemiaMahesh M Umapathysivam, Michael Y Lee, Karen L Jones, et al.Journal of Diabetes Science and Technology|October 22, 2019
Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII)Michael A Nauck, Anna M Lindmeyer, Chantal Mathieu, et al.Regulatory Peptides|July 26, 2002
Gastric inhibitory polypeptide: the neglected incretin revisitedJuris J Meier, Michael A Nauck, Wolfgang E Schmidt, et al.Nature Reviews. Endocrinology|November 14, 2020
COVID-19 and diabetes mellitus: from pathophysiology to clinical managementSoo Lim, Jae Hyun Bae, Hyuk-Sang Kwon, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 15, 2019
Clinical Predictors of the Need for Further Treatment Escalation in Patients with Type 2 Diabetes on Basal Insulin Therapy - A Retrospective Observational StudyChristina Buchholz, Melanie Kahle-Stephan, Juris J Meier, et al.Pageof 69